EG ·
ATACAND plus 32/25 MG 14tab
ATACAND plus 32/25 MG 14tab
Composition
These source-reported data require scientific review and are not treatment advice.
CANDESARTAN
16.00000 MG · AMOUNT_PER_UNIT
Registration
Packages and prices
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| ATACAND 8 MG 28 TAB | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis, dosage_form | — EGP |
| BLOPRESS PLUS 16MG 28/TAB # | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis, dosage_form | — EGP |
| ATACAND 16MG 14TAB | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis | — EGP |
| BLOPRESS PLUS 8MG 28/TAB # | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis, dosage_form | — EGP |
| ATACAND 8mg 14/TAB | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis, dosage_form | — EGP |
| ATACAND PLUS 16/12.5MG 14TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| ALBUSTIX 8 MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| ATACAND 4 MG 14 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| ALBUSTIX 8 MG 10 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| BLOPRESS 16MG 28/TAB # | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| CANDESAR 8MG 14/TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| BLOPRESS 8MG 28/TAB # | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |